Oct 30, 2025 / NTS GMT
Presentation
Oct 30, 2025 / NTS GMT
=====================
Corporate Participants
=====================
* Nobuko Kato
Astellas Pharma Inc - Chief Communications & IR Officer
* Naoki Okamura
Astellas Pharma Inc - President, Chief Executive Officer, Representative Director
* Tadaaki Taniguchi
Astellas Pharma Inc - Chief Research and Development Officer
* Claus Zieler
Astellas Pharma Inc - Chief Commercial & Medical Affairs Officer
* Atsushi Kitamura
Astellas Pharma Inc - Senior Managing Executive Officer, Chief Financial Officer
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc - Analyst
* Seiji Wakao
JPMorgan Securities Japan Co Ltd - Analyst
* Akinori Ueda
Goldman Sachs Japan Co Ltd - Analyst
* Hiroyuki Matsubara
Nomura Securities International Inc - Analyst
* Fumiyoshi Sakai
UBS Securities Japan Co Ltd - Analyst
* Shinichiro Muraoka
Astellas Pharma Inc
(STU:YPH)
€
11.4
+0.10 (+0.88%)
Market Cap: 20.87 Bil
Enterprise Value: 22.37 Bil
PE Ratio: 13.32
PB Ratio: 2.12
GF Score: 83/100 Q2 2026 Astellas Pharma Inc Earnings Presentation Transcript
Oct 30, 2025 / NTS GMT
Release Date Price:
€8.84
(+0.96%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot